Medivation, Inc. (NASDAQ: MDVN) today reiterated its rejection of Sanofi's (NYSE: SNY) substantially inadequate proposal to acquire the Company for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE